JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. (Q37623539)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 December 2013
edit
Language Label Description Also known as
English
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
scientific article published on 23 December 2013

    Statements

    JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes (English)
    Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit